Assessment of plateletphersis donation in Tehran Blood Center

Additional and more effective platelets can be gained through plateletphersis which at times equals platelets of 8 units of blood. Patients are exposed to a less number of donors through prescription of such platelets. Although side-effects of plateletphersis are low among donors but side-effects vary at different centers. Illustration of plateletphersis production side-effects at Tehran Blood Bank is the aim. This is a retrospective study on plateletphersis donors from 2005 to March 2011. Research was carried on 309 total blood donors who met Iran blood transfusion standards; CBC was carried out on all donors and those with Hb and platelet higher than 12. 5 and 150. 000 were entered into the study. Information regarding aphersis sessions was compiled in donors’ forms including side-effects during platelet donation and they were classified as mild، intermediate and severe according to definition. In the study، 302 cases of plateletphersis were carried out in which 81% of donors were male and 19% female; while the mean age of donors was 35. 3 ± 9. 8. The most occurring side-effects among donors were mild/medium vasovagal donation reaction 1. 6% and citrate poisoning 1. 6% of which 0. 3% was of the intermediate type. Plateletphersis is safe and occurrence of side-effects is low. Side-effects occur mostly among younger and first time donors.